David G. DeNardo

1997–2026 年に発表

88
論文数
25,659
被引用数
62
h 指数
84
i10 指数

被引用数

David G. DeNardo の年別被引用数2002 年: 被引用 1 件2003 年: 被引用 3 件2005 年: 被引用 5 件2006 年: 被引用 10 件2007 年: 被引用 10 件2008 年: 被引用 36 件2009 年: 被引用 44 件2010 年: 被引用 123 件2011 年: 被引用 197 件2012 年: 被引用 169 件2013 年: 被引用 232 件2014 年: 被引用 208 件2015 年: 被引用 244 件2016 年: 被引用 275 件2017 年: 被引用 377 件2018 年: 被引用 398 件2019 年: 被引用 973 件2020 年: 被引用 1,461 件2021 年: 被引用 1,905 件2022 年: 被引用 1,689 件2023 年: 被引用 1,449 件2024 年: 被引用 2,051 件2025 年: 被引用 1,236 件2026 年: 被引用 54 件2004 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,698 件、この内訳の 26%中国: 引用元論文 3,262 件、この内訳の 22.9%イギリス: 引用元論文 700 件、この内訳の 4.9%ドイツ: 引用元論文 632 件、この内訳の 4.4%イタリア: 引用元論文 586 件、この内訳の 4.1%フランス: 引用元論文 477 件、この内訳の 3.3%日本: 引用元論文 405 件、この内訳の 2.8%オーストラリア: 引用元論文 307 件、この内訳の 2.2%オランダ: 引用元論文 292 件、この内訳の 2.1%スペイン: 引用元論文 283 件、この内訳の 2%カナダ: 引用元論文 277 件、この内訳の 1.9%スイス: 引用元論文 261 件、この内訳の 1.8%
0%26%その他 21.6%

分野

  • Medicine43.3%
  • Immunology and Microbiology27.5%
  • Biochemistry, Genetics and Molecular Biology22.1%
  • Engineering3.3%
  • Neuroscience1.3%
  • Materials Science1%
  • その他1.5%

トピック

  • Immune cells in cancer11.4%
  • Cancer Immunotherapy and Biomarkers8.3%
  • Cancer Cells and Metastasis5.5%
  • Immunotherapy and Immune Responses4.6%
  • Immune Cell Function and Interaction3.8%
  • Pancreatic and Hepatic Oncology Research3.1%
  • その他63.3%

共著者

全論文

検索で開く
  1. A framework for advancing our understanding of cancer-associated fibroblasts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2020 被引用: 3,780

  2. Macrophages as regulators of tumour immunity and immunotherapy

    著者: , - Nature reviews. Immunology 2019 被引用: 2,534

  3. CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

    著者: , , , , , , , , , - Cancer Research 2014 被引用: 1,287

  4. Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

    著者: , , , , , , , , , , , , , , - Immunity 2017 被引用: 786

  5. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 778

  6. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

    著者: , , , , , , , , , , , , - Nature Medicine 2016 被引用: 1,034

  7. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis

    著者: , , , , , , , , , , , , , , , - Nature Communications 2016 被引用: 473

  8. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 458

  9. Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

    著者: , , , , , , , , , , , , , , - Gut 2017 被引用: 481

  10. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth L. Appelbaum, Keenan J. Robbins, Sara E. Chasnoff, Xiaolu Yang, Ashley N. Reeb, Clara Oh, Mamatha Serasanambati, Preet Lal, Rajees Varghese, Jay R. Mashl, Jennifer Ponce, Nadezhda V. Terekhanova, Lijun Yao, Fang Wang, Lijun Chen, Michael Schnaubelt, Rita Jui-Hsien Lu, Julie K. Schwarz, Sidharth V. Puram, Albert H. Kim, Sheng‐Kwei Song, Kooresh I. Shoghi, Ken S. Lau, Tao Ju, Ken Chen, Deyali Chatterjee, William G. Hawkins, Hui Zhang, Samuel Achilefu, Milan G. Chheda, Stephen T. Oh, William E. Gillanders, Feng Chen, David G. DeNardo, Ryan C. Fields, Li Ding - Nature Genetics 2022 被引用: 287

  11. CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages

    著者: , , , , , , - Cancer Cell 2009 被引用: 1,338

  12. Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

    著者: , , , , , , , , , , , , , , - Cancer Discovery 2011 被引用: 1,718

  13. Epigenetic regulation during cancer transitions across 11 tumour types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Russell K. Pachynski, Julie K. Schwarz, William E. Gillanders, Albert H. Kim, Ravi Vij, John F. DiPersio, Sidharth V. Puram, Milan G. Chheda, Katherine C. Fuh, David G. DeNardo, Ryan C. Fields, Feng Chen, Benjamin J. Raphael, Li Ding - Nature 2023 被引用: 200

  14. Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

    著者: , , , , , , , , , , , , , , , , , , - Cancer Research 2012 被引用: 941

  15. Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression

    著者: , , , , , , , , , , , , , , , , , , - Cancer Discovery 2024 被引用: 144

  16. Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression

    著者: , , , , , , , , , - Cancer Research 2010 被引用: 628

  17. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , - Cancer Discovery 2024 被引用: 104

  18. Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

    著者: , , , , , , , , , , , , , , - Clinical Cancer Research 2013 被引用: 613

  19. Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 被引用: 92

  20. Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 被引用: 105

  21. Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 被引用: 106

  22. Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma

    著者: , , , , , , , , , , , , - Science Translational Medicine 2023 被引用: 97

  23. Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC

    著者: , , , , , , , , , , , , , , , , , , - Nature Immunology 2023 被引用: 86

  24. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

    著者: , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 213